Based on these findings, a diagnosis of glioblastoma, IDH-wildtype was made according to the 2021 updated 5th WHO Classification of Tumors of the Central Nervous System (WHO CNS5) criteria. The gene discussed is IDH1; the disease is glioblastoma.